Literature DB >> 25037735

Multidrug resistant Acinetobacter baumannii reaches a new frontier: prosthetic hip joint infection.

G T R Hischebeth1, M D Wimmer, E Molitor, H Seifert, S Gravius, I Bekeredjian-Ding.   

Abstract

Acinetobacter baumannii is an emerging nosocomial pathogen primarily in countries with a high prevalence of multidrug resistance. Here we report the detection of a bla OXA23 carbapenemase-producing A. baumannii strain in a German patient with prosthetic hip joint infection following several hip joint surgeries but no history of foreign travel.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25037735     DOI： 10.1007/s15010-014-0661-x

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  17 in total

1.  In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.

Authors:  Luigi Principe; Alessandro Capone; Antonio Mazzarelli; Silvia D'Arezzo; Eugenio Bordi; Antonino Di Caro; Nicola Petrosillo
Journal:  Microb Drug Resist       Date:  2013-05-09       Impact factor: 3.431

2.  Occurrence of blaOXA-23 gene in imipenem-susceptible Acinetobacter baumannii.

Authors:  Karyne Rangel Carvalho; Ana Paula D'Alincourt Carvalho-Assef; Lia Galvão dos Santos; Maria José Félix Pereira; Marise Dutra Asensi
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-06       Impact factor: 2.743

3.  Active surveillance for asymptomatic colonization with multidrug-resistant gram negative bacilli among injured service members--a three year evaluation.

Authors:  Amy C Weintrob; Clinton K Murray; Bradley Lloyd; Ping Li; Dan Lu; Zhuang Miao; Deepak Aggarwal; M Leigh Carson; Lakisha J Gaskins; David R Tribble
Journal:  MSMR       Date:  2013-08

Review 4.  Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis.

Authors:  Benedetta Allegranzi; Sepideh Bagheri Nejad; Christophe Combescure; Wilco Graafmans; Homa Attar; Liam Donaldson; Didier Pittet
Journal:  Lancet       Date:  2010-12-09       Impact factor: 79.321

5.  Role of OXA-23 and AdeABC efflux pump for acquiring carbapenem resistance in an Acinetobacter baumannii strain carrying the blaOXA-66 gene.

Authors:  Yangsoon Lee; Jong Hwa Yum; Chang-Ki Kim; Dongeun Yong; Eun Hee Jeon; Seok Hoon Jeong; Jee Young Ahn; Kyungwon Lee
Journal:  Ann Clin Lab Sci       Date:  2010       Impact factor: 1.256

Review 6.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii.

Authors:  M H Rigatto; V B Ribeiro; D Konzen; A P Zavascki
Journal:  Infection       Date:  2012-11-04       Impact factor: 3.553

8.  Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London.

Authors:  David M Livermore; Robert L R Hill; Hazel Thomson; André Charlett; Jane F Turton; Rachel Pike; Bharat C Patel; Rohini Manuel; Stephen Gillespie; Indran Balakrishnan; Stephen P Barrett; Nigel Cumberland; Mary Twagira
Journal:  Int J Antimicrob Agents       Date:  2009-11-11       Impact factor: 5.283

9.  Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements.

Authors:  Lingxiang Zhu; Zhongqiang Yan; Zhaojun Zhang; Qiming Zhou; Jinchun Zhou; Edward K Wakeland; Xiangdong Fang; Zhenyu Xuan; Dingxia Shen; Quan-Zhen Li
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Carbapenem-resistant Acinetobacter baumannii from Brazil: role of carO alleles expression and blaOXA-23 gene.

Authors:  Erica Lourenço Fonseca; Erica Scheidegger; Fernanda S Freitas; Rosângela Cipriano; Ana Carolina P Vicente
Journal:  BMC Microbiol       Date:  2013-11-06       Impact factor: 3.605
View more
  5 in total

Review 1.  Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

2.  Prolonging culture to 15 days improves bacterial detection in bone and joint infections.

Authors:  L Drago; E De Vecchi; L Cappelletti; C Vassena; M Toscano; M Bortolin; R Mattina; C L Romanò
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-09       Impact factor: 3.267

3.  Acute Periprosthetic Hip Joint Infection Caused by Multidrug-Resistant Acinetobacter Baumannii: Is Debridement, Antibiotics, Irrigation, and Implant Retention a Viable Treatment Option?

Authors:  Angelo V Vasiliadis; Frideriki Poutoglidou; Vasiliki Chatziravdeli; Dimitrios Metaxiotis; Anastasios Beletsiotis
Journal:  Cureus       Date:  2021-02-03

Review 4.  Spatio-Temporal Distribution of Acinetobacter baumannii in Germany-A Comprehensive Systematic Review of Studies on Resistance Development in Humans (2000-2018).

Authors:  Gamal Wareth; Christian Brandt; Lisa D Sprague; Heinrich Neubauer; Mathias W Pletz
Journal:  Microorganisms       Date:  2020-03-06

5.  Non-elective and revision arthroplasty are independently associated with hip and knee prosthetic joint infection caused by Acinetobacter baumannii: a Brazilian single center observational cohort study of 98 patients.

Authors:  Raquel Bandeira da Silva; Rodrigo Otavio Araujo; Mauro José Salles
Journal:  BMC Musculoskelet Disord       Date:  2021-06-02       Impact factor: 2.362
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.